Low variability in peak expiratory flow predicts successful inhaled corticosteroid step-down in adults with asthma
The Journal of Allergy and Clinical Immunology: In Practice Dec 11, 2017
Tsurikisawa N, et al. - This study was designed to identify the factors that could help predict treatment success when assessed before the initiation of asthma treatment or at inhaled corticosteroid (ICS) dose reduction. As per the findings, the following factors displayed usefulness for predicting that an adult's asthma will remain in control for months to years after a 50% reduction in the daily ICS dose: low peak expiratory flow variability over 1 week, high serum IL-10 level, and low serum IL-33 concentration.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries